Measurement of serum antibodies against native Leishmania gp63 distinguishes between ongoing and previous L. donovani infection.
An enzyme-linked immunosorbent assay (ELISA) using native gp63 for detection of serum antibodies to Leishmania was evaluated. The test identified antibodies in sera from 16 of 16 visceral leishmaniasis (VL) patients and 9 of 12 sera from patients with Trypanosoma brucei infection. In comparison, sera from 80 Danish controls and 40 control donors from a malaria endemic area of Ghana without known exposure to Leishmania were negative, as were sera from 12 Kenyan malaria patients and 9 schistosomiasis patients. After cure of VL, sera rapidly became negative. Only 1 of 7, 1 of 21, and 1 of 27 sera from cured VL patients 6-12 months, 1-2 years and > 2 years after cure were positive. Thus, in contrast to other serological tests for VL, the gp63 ELISA seems to distinguish an ongoing from a past infection. This might prove useful both for diagnostic and epidemiological purposes.
Okong'o-Odera
E A
EA
Biomedical Sciences Research Centre, Kenya Medical Research Institute, Nairobi.
Kurtzhals
J A
JA
Hey
A S
AS
Kharazmi
A
A
D000818:Animals; D000909:Antibodies, Helminth / Q000032:analysis; D000913:Antibodies, Protozoan / Q000032:analysis*; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D007630:Kenya / Q000453:epidemiology; D007893:Leishmania donovani / Q000276:immunology* / Q000378:metabolism; D007898:Leishmaniasis, Visceral / Q000175:diagnosis* / Q000453:epidemiology / Q000276:immunology; D008666:Metalloendopeptidases / Q000276:immunology* / Q000378:metabolism; D015800:Protozoan Proteins / Q000276:immunology* / Q000378:metabolism; D012550:Schistosoma mansoni / Q000276:immunology; D014346:Trypanosoma brucei brucei / Q000276:immunology; D014353:Trypanosomiasis, African / Q000175:diagnosis / Q000276:immunology
D000909:Antibodies, Helminth; D000913:Antibodies, Protozoan; D015800:Protozoan Proteins; D008666:Metalloendopeptidases; C055146:glycoprotein gp63, Leishmania